Back
Viking Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
35
VKTX
Viking Therapeutics, Inc.
Last Price:
$31.88
Seasonality Move:
4.84%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bullish and VKTX is experiencing slight selling pressure.
Viking Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 32.95 | Buy |
| 20-day SMA: | 30.7 | Buy |
| 50-day SMA: | 32.3 | Buy |
| 200-day SMA: | 31.53 | Buy |
| 8-day EMA: | 29.69 | Buy |
| 20-day EMA: | 19.52 | Buy |
| 50-day EMA: | 9.9 | Buy |
| 200-day EMA: | 2.81 | Buy |
Viking Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 9.27 | Buy |
| Relative Strength Index (14 RSI): | 56.17 | Buy |
| Chaikin Money Flow: | -508624 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
Viking Therapeutics, Inc. Technical Analysis
| Feb 18 | Feb 19 | Feb 20 | Feb 23 | Feb 24 | Feb 25 | Feb 26 | Feb 27 | Mar 2 | Mar 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb | Mar | |||||||||
| 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Viking Therapeutics, Inc. Stock
Is Viking Therapeutics, Inc. Stock a Buy?
-
Viking Therapeutics, Inc. share price is 33.34 while VKTX 8-day simple moving average is 32.95, which is a Buy signal.
-
The stock price of VKTX is 33.34 while Viking Therapeutics, Inc. 20-day SMA is 30.70, which makes it a Buy.
-
Viking Therapeutics, Inc. 50-day simple moving average is 32.30 while VKTX share price is 33.34, making it a Buy technically.
-
VKTX stock price is 33.34 and Viking Therapeutics, Inc. 200-day simple moving average is 31.53, creating a Buy signal.
VKTX Technical Analysis vs Fundamental Analysis
Sell
35
Viking Therapeutics, Inc. (VKTX)
is a Sell
Is Viking Therapeutics, Inc. a Buy or a Sell?
-
Viking Therapeutics, Inc. stock is rated a SellThe current Viking Therapeutics, Inc. [VKTX] share price is $33.34. The Score for VKTX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
Viking Therapeutics, Inc. Stock Info
Market Cap:
3.9B
Price in USD:
33.34
Share Volume:
2M
Viking Therapeutics, Inc. 52-Week Range
52-Week High:
43.15
52-Week Low:
18.92
Sell
35
Viking Therapeutics, Inc. (VKTX)
is a Sell
Viking Therapeutics, Inc. Share Price Forecast
-
What is the Viking Therapeutics, Inc. stock price today?The Viking Therapeutics, Inc. stock price is 33.34 USD today.
-
Will VKTX stock go up or go down?Viking Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Viking Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Viking Therapeutics, Inc. is overvalued.
Is Viking Therapeutics, Inc. Stock a Buy?
-
Viking Therapeutics, Inc. share price is 33.34 while VKTX 8-day exponential moving average is 29.69, which is a Buy signal.
-
The stock price of VKTX is 33.34 while Viking Therapeutics, Inc. 20-day EMA is 19.52, which makes it a Buy.
-
Viking Therapeutics, Inc. 50-day exponential moving average is 9.90 while VKTX share price is 33.34, making it a Buy technically.
-
VKTX stock price is 33.34 and Viking Therapeutics, Inc. 200-day simple moving average is 2.81, creating a Buy signal.
Fundamental Analysis of Viking Therapeutics, Inc.
Is Viking Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.39 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.50 per share, and a decrease next year of $0.46 per share.
Technical Analysis of Viking Therapeutics, Inc.
Should I short Viking Therapeutics, Inc. stock?
-
VKTX Moving Average Covergence Divergence (MACD) indicator is 9.27, suggesting Viking Therapeutics, Inc. is a Buy
-
Viking Therapeutics, Inc. Relative Strength Index (RSI) is 56.17, which suggest Viking Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Viking Therapeutics, Inc. is ( - ), which suggest Viking Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Viking Therapeutics, Inc. is ( - ), which suggest Viking Therapeutics, Inc. is a Buy
* Viking Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.